Preoperative serum CA-125 level as a predictor for the extent of cytoreduction in patients with advanced stage epithelial ovarian cancer Cover

.blurhash-client-img { display: none !important; }

Preoperative serum CA-125 level as a predictor for the extent of cytoreduction in patients with advanced stage epithelial ovarian cancer

Radiology and Oncology

Volume 55 (2021): Issue 3 (September 2021)

By: Sebastjan Merlo, Nikola Besic, Eva Drmota and Nina Kovacevic

Open Access

|Aug 2021

Authors

Sebastjan Merlo

Department of Gynaecological Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Nikola Besic

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Department of Surgical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Eva Drmota

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Nina Kovacevic

nkovacevic@onko-i.si

Department of Gynaecological Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Faculty of Health Care Angele Boškin, Jesenice, Slovenia

DOI: https://doi.org/10.2478/raon-2021-0013 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 341 - 346

Submitted on: Nov 25, 2020

Accepted on: Feb 9, 2021

Published on: Aug 10, 2021

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

ovarian cancer,

primary debulking surgery,

neoadjuvant chemotherapy

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2021 Sebastjan Merlo, Nikola Besic, Eva Drmota, Nina Kovacevic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 55 (2021): Issue 3 (September 2021)Next article